These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20521806)

  • 1. How does influenza virus a escape from amantadine?
    Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
    J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why amantadine loses its function in influenza m2 mutants: MD simulations.
    Laohpongspaisan C; Rungrotmongkol T; Intharathep P; Malaisree M; Decha P; Aruksakunwong O; Sompornpisut P; Hannongbua S
    J Chem Inf Model; 2009 Apr; 49(4):847-52. PubMed ID: 19281265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.
    Wang JF; Chou KC
    Protein Eng Des Sel; 2010 Aug; 23(8):663-6. PubMed ID: 20571121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2.
    Gleed ML; Ioannidis H; Kolocouris A; Busath DD
    J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free energy calculations on the two drug binding sites in the M2 proton channel.
    Gu RX; Liu LA; Wei DQ; Du JG; Liu L; Liu H
    J Am Chem Soc; 2011 Jul; 133(28):10817-25. PubMed ID: 21711026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.
    Gu RX; Liu LA; Wang YH; Xu Q; Wei DQ
    J Phys Chem B; 2013 May; 117(20):6042-51. PubMed ID: 23594107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
    J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
    Nguyen H; Le L
    Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the M2 protein in influenza virus membrane fusion: effects of amantadine and monensin on fusion kinetics.
    Bron R; Kendal AP; Klenk HD; Wilschut J
    Virology; 1993 Aug; 195(2):808-11. PubMed ID: 8337846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N).
    Gleed ML; Busath DD
    J Phys Chem B; 2015 Jan; 119(3):1225-31. PubMed ID: 25426702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells.
    Wang C; Lamb RA; Pinto LH
    Virology; 1994 Nov; 205(1):133-40. PubMed ID: 7526533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
    Du QS; Huang RB; Wang CH; Li XM; Chou KC
    J Theor Biol; 2009 Jul; 259(1):159-64. PubMed ID: 19285514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.
    Hata M; Tsuzuki M; Goto Y; Kumagai N; Harada M; Hashimoto M; Tanaka S; Sakae K; Kimura T; Minagawa H; Miyazaki Y
    Jpn J Infect Dis; 2007 Jul; 60(4):202-4. PubMed ID: 17642534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.
    Saito R; Li D; Suzuki Y; Sato I; Masaki H; Nishimura H; Kawashima T; Shirahige Y; Shimomura C; Asoh N; Degawa S; Ishikawa H; Sato M; Shobugawa Y; Suzuki H
    J Med Virol; 2007 Oct; 79(10):1569-76. PubMed ID: 17705168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
    Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
    Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.